In Vivo Measurement Articles & Analysis
4 articles found
The efficacy and toxicity of drugs in vivo can be predicted by measuring the composition and number of the gut microbiome and the relative abundance of its metabolites. ...
Compounds are required to be characterized thoroughly for ADME properties prior to regulatory approval, and during preclinical drug discovery/development act as key attributes that can determine the compound’s prioritization for further testing1.Thestandard in vivo assay for ADME characterization is the measurement of plasma concentrations over time after ...
To improve current bioaccumulation assessment methods, a methodology is developed, applied and investigated for measuring in vivo biotransformation rates of hydrophobic organic substances in the body (soma) and gastro‐intestinal tract of the fish. ...
Mutants lacking both glutaredoxins display reduced sensitivity to tunicamycin, although the drug is still able to manifest its inhibitory effect on a reporter glycoprotein. Grx6 and Grx7 have measurable oxidoreductase activity in vivo, which is increased in the presence of tunicamycin. ...